Gender-Responsive Drug Use Treatment for Juvenile Justice Girls

对少年司法女孩进行性别敏感的吸毒治疗

基本信息

批准号：
9130919
负责人：
MARINA TOLOU-SHAMS
金额：
$ 62.03万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-01 至 2019-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9130919
关键词：
AIDS/HIV problem Adolescent Adult Age Aggressive behavior Alcohol consumption Alcohol or Other Drugs use Attenuated Behavior Behavior Therapy Biological Chlamydia Communication Development Diagnosis Disease Drug usage Evidence based intervention Family Female Female Adolescents Functional disorder Gender Gender Identity HIV HIV risk HIV/STD Health Imprisonment Incidence Individual Interpersonal Relations Intervention Justice Juvenile Delinquency Knowledge Legal Measures Mediator of activation protein Mental Health Minor Modeling Nature Outcome Partner Communications Pathway interactions Pharmacotherapy Phase Pilot Projects Population Pregnancy Outcome Procedures Prostitution Public Health Publishing Randomized Recording of previous events Recruitment Activity Research Rhode Island Risk Risk Behaviors Running Sampling Scientific Advances and Accomplishments Self Efficacy Sexual abuse Sexually Transmitted Diseases Specimen Staging Statistical Models Substance Use Disorder Substance abuse problem Testing Trauma Treatment outcome Victimization Woman adolescent drug use base behavioral outcome boys clinical practice court demographics efficacy testing efficacy trial evidence base field study girls improved juvenile justice system male offender peer physical conditioning post intervention primary outcome programs psychiatric symptom recidivism reduced substance use secondary outcome self esteem sex risk skills standard of care treatment trial

项目摘要

DESCRIPTION (provided by applicant): Compared to both non-offending females and male offending counterparts, offending girls are at significantly greater risk for the development of substance use disorders, psychiatric symptoms and negative health outcomes, such as HIV/AIDS or other sexually transmitted infections (STIs). Research suggests that girls may have different developmental pathways to drug use, initial legal involvement and co-occurring negative health outcomes that support the importance of testing gender-specific treatments for juvenile justice girls. Although there is recent increased emphasis on gender-specific programming in juvenile justice, empirically supported gender specific interventions to improve health, mental health and/or legal outcomes among juvenile justice girls are lacking. The objective of this Stage II treatment trial is therefore to test the efficacy of a pre-existing, widly disseminated gender-responsive drug use treatment (VOICES) among 200 court-involved, non- incarcerated (CINI) girls. We seek to test the effect of VOICES on CINI girls' drug and alcohol use, HIV/STI risk, psychiatric symptoms and recidivism as well as explore moderators and mediators of outcomes. CINI girls, ages 12-18 (N= 6 juveniles for Phase I Intervention Run-Through; N=200 for Phase II RCT study) will be recruited from the Rhode Island Family Court and randomized to either the VOICES (active) intervention (n=100) or a Standard of Care (control) condition (n=100). In Phase I (first six months of Year 1), 6 juveniles will be recruitedto complete the Intervention Run-Through and research assessment once to allow testing of RCT intervention and assessment procedures prior to the RCT phase. In Phase II (last half of Year 1 through Year 4), 200 juveniles will be recruited and randomized at baseline and then re-assessed at mid-treatment, end of treatment, and 3, 6, 9 and 12 month post-intervention follow-ups. Biological specimens for juvenile drug use and sexually transmitted infections (STIs) will also be collected at each 3-month assessment. Efficacy trial results can be used to make immediate changes to current widespread program delivery resulting in direct impact on the field of evidence-based gender-responsive substance use interventions for juvenile justice girls.

描述（由申请人提供）：与无罪的女性和男性犯罪同行相比，犯罪的女孩的出现风险明显更大，出现使用疾病，精神病症状和负面健康结果，例如HIV/AIDS或其他性传播感染（STIS）。研究表明，女孩可能有不同的发展途径，最初的法律参与以及共同发生的负面健康结果，这些结果支持对少年司法女孩测试特定性别治疗的重要性。尽管最近在少年司法中越来越重视针对性的针对性别的节目，但缺乏在少年司法女孩中改善健康，心理健康和/或法律成果的经验支持的特定性别干预措施。因此，该阶段II治疗试验的目的是测试在200名涉及法院，无监禁的（CINI）女孩中，先前存在的，广泛传播性别响应性药物使用治疗（Voices）的功效。我们试图测试声音对Cini Girls毒品和酒精使用，HIV/STI风险，精神病症状和累犯的影响，并探索结果的主持人和调解人。 Cini Girls，年龄在12-18岁（n = 6阶段的少年干预术； II期RCT研究的n = 200）将从罗德岛家族法院招募，并随机分配给声音（主动）干预（n = 100）或标准的护理（控制）条件（控制）条件（n = 100）。在第一阶段（第1年的前六个月）中，将招募6名少年，以完成一次干预和研究评估，以允许在RCT阶段之前测试RCT干预和评估程序。在第二阶段（第一年的最后一年级至4年级）中，将在基线时招募和随机分配200名少年，然后在治疗中期，治疗终结和3、6、9和12个月的干预后随访。在每个3个月的评估中，还将收集用于少年药物使用和性传播感染（STI）的生物标本。疗效试验结果可用于立即改变当前的广泛计划，从而直接影响基于证据的性别反应性药物使用干预措施对少年司法女孩的干预措施。